INSPIRIS | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

197 results for “INSPIRIS”

Trials

View all 156 →

Active, not recruiting

Inspiris Resilia Durability Registry

400 participants · First posted Sep 12, 2018

Active, not recruiting

INSPIRIS China PMCF Study

255 participants · First posted Jun 3, 2022

INSPIRIS RESILIA Valve in Pulmonary Position

40 participants · First posted Oct 18, 2022

Drugs

insparin

RGX-019-MMAE(Inspirna)

P2X3 purinergic receptor antagonists (Inspire)

Organizations

Inspirna, Inc.

United States

SUPER INSPIRED LLC

United States

LIVE INSPIRED, LLC

United States

News

View all 29 →

Edwards Lifesciences Receives FDA Approval for TAVR Therapy in Asymptomatic Severe Aortic Stenosis

Inspira Technologies Expands European Footprint with Innovimed Agreement for INSPIRA ART Clinical Trials

Schwann Cell Therapy Aids Paralysis Recovery, Inspires Patient's Medical Career

Page 1 of 20